850705-46-3Relevant academic research and scientific papers
CFTR channel modulators
-
Page/Page column 16, (2008/06/13)
The invention concerns pharmaceutical formulas designed for the treatment of diseases related to CFTR channel dysfunction, such as cystic fibrosis, asthma or diarrhoea. These formulas contain a molecule, coming in the form of a zwitterion at physiological pH, with the formula: where XN or P; YO or S; R1 to R7 represent: -, H, or carbon chains, substituted or not, which may contain heteroatoms; except for betaine.
